CliffBio
small molecule

NORGESTIMATE AND ETHINYL ESTRADIOL

ETHINYL ESTRADIOL; NORGESTIMATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameNORGESTIMATE AND ETHINYL ESTRADIOL
Active ingredientETHINYL ESTRADIOL; NORGESTIMATE
Strength0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.